May 20, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leader in developing liquid biopsy tests for early cancer detection, today announced the publication of a ...

Annual Conference, Vitalograph and Thorasys announced a strategic partnership that further integrates oscillometry technology into Vitalograph's respiratory diagnostics portfolio.

The administration is not only allowing more greenhouse gases. It is undermining the nation’s ability to understand and ...

The latest results from the phase 3 FIBRONEER-IPF trial showed consistent benefit of nerandomilast in patients with ...

Patients with moderate to severe asthma saw increases in FEV1 within 24 hours after taking a loading dose of rademikibart, ...

Researchers are working to redefine diagnosis and treatment with data-driven tools aimed at identifying patients earlier and ...

In celebration of its 120th anniversary, the American Lung Association is joining with the American College of Chest Physicians (CHEST) to announce the opening of applications for the CHEST/ALA ...

Study Identifies New Method for Improving Lung Growth and Function in Preterm Infants Apr. 17, 2025 — A clinical trial conducted in a neonatal intensive care unit has identified a new treatment ...

A new study suggests that methylene blue—a medication already approved for several clinical uses—may protect the lungs from ...

2022.799912. PMID: 35178411; PMCID: PMC8843847. Assuming a world population of 8bn Share this Story : Global phase III trials demonstrate that nerandomilast slowed lung function decline in IPF and PPF ...